Opthametry

KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of treating keratoconus with additive keratoplasty.“Whether that’s CTAK or CAIRS, we now have a fairly noninvasive surgical way, especially compared with corneal transplantation, to help patients improve their vision, whether it’s uncorrected visual acuity, spectacle corrected visual…

The FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, according to a press release from Outlook Therapeutics.The approval of Lytenava is marks the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the United States.Bevacizumab-vikg, a recombinant humanized IgG1 monoclonal antibody specific for human VEGF, binds…

LAS VEGAS — Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according to a presentation at Clinical Trials at the Summit.Arshad Khanani, MD, MA, FASRS, of Sierra Eye Associates in Reno, Nevada, presented initial findings from the first cohort of patients enrolled in the phase 1/2 Opti-GAIN study. The primary…

The first patient has been enrolled in the phase 3 Galassia-NAION-301 study to evaluate an intranasal spray for the treatment of nonarteritic anterior ischemic optic neuropathy, according to a press release from Dompé.If approved, it would be the first FDA-approved treatment for nonarteritic anterior ischemic optic neuropathy (NAION), a spontaneous vision loss that can lead…

The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million have moderate to severe visual impairment.The International Agency for the Prevention of Blindness states that 1.1 billion of the world’s 8 billion people suffer from visual impairment.About 90% of people with vision impairment live in…

Healio AI and the American Society of Cataract and Refractive Surgery, or ASCRS, announced a partnership to optimize available educational resources for ophthalmologists, according to a press release.The collaboration adds the clinical educational content from the 2026 ASCRCS Annual Meeting — which offered over 300 hours of educational opportunities — to Healio AI’s expanding knowledge…

Click here to read the Point/Counter to this Cover Story.Through the combined efforts of local governments, pioneering institutions, global health alliances and nongovernmental organizations, the integration of eye care services in low-resource areas of the developing world is making progress.Innovative care delivery models and outreach programs have been successfully implemented, and technological advances have played…

The FDA favorably reviewed plans for a phase 3 trial of urcosimod, which is being investigated for the treatment of neuropathic corneal pain, according to a press release from Okyo Pharma.The feedback came during a meeting between Okyo Pharma and the FDA, paving the way for a pivotal trial in a disease that currently has…

More than 2.5 million bottles of steroid eye drops aimed at relieving inflammation have been recalled, according to the FDA.Lupin Pharmaceuticals is recalling 2,530,182 bottles of prednisolone acetate ophthalmic solution 1%, including 5 mL, 10 mL and 15 mL bottles. The affected lots have expiration dates ranging from July 31, 2026, to March 31, 2028.The…

Healio has garnered six APEX awards, including one Grand Award, this year.The APEX awards highlight outstanding achievement in graphic design, editorial content and overall communications excellence. Each year, over 1,000 submissions are selected for Awards of Excellence and Grand Awards.“Our editorial, design, and marketing teams work tirelessly to serve the medical community,” Matthew Holland, chief…